DG Capital Management (Massachusetts)’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2013
Q4
Sell
-109,050
Closed -$1.84M 69
2013
Q3
$1.84M Sell
109,050
-33,000
-23% -$555K 1.05% 47
2013
Q2
$2.2M Buy
+142,050
New +$2.36M 1.33% 45

Other funds holding NVO

DG Capital Management (Massachusetts)'s NVO Position: Q4 2013 in Review

DG Capital Management (Massachusetts) sold out of Novo Nordisk (NVO) in Q4 2013, closing a stake of 109,050 shares — an estimated $1.84M sold.

DG Capital Management (Massachusetts) first reported a position in NVO in Q2 2013 and held it in 2 quarters. The position peaked at $2.2M in Q2 2013. 431 funds tracked by Wall St. Rank hold NVO as of Q4 2013.

  • DG Capital Management (Massachusetts) reported no remaining Novo Nordisk position as of Q4 2013 after selling out during the quarter.
  • DG Capital Management (Massachusetts) sold 109,050 Novo Nordisk shares in Q4 2013, an estimated $1.84M.
  • DG Capital Management (Massachusetts) first reported a position in Novo Nordisk in Q2 2013 and held it in 2 quarters.
  • DG Capital Management (Massachusetts)'s Novo Nordisk position peaked at $2.2M in Q2 2013.
  • 431 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2013.

Based on DG Capital Management (Massachusetts)'s 13F filing for Q4 2013, filed 12 Feb 2014.